Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Body temperature, Chest X-ray, Heart rate, Oedema, Oxygen saturation, Cerebral haematoma, Computerised tomogram head, Blood pressure measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Hematoma cerebral/acute intraparenchymal hematoma in the right capsular thalamus region with an intraventricular component; Lower limbs with pitting edema in right lower limb; This is a spontaneous report from a contactable physician downloaded from The Regulatory Authority-WEB. Regulatory authority report number is ES-AEMPS-771065. A 74-year-old male patient received first dose of BNT162B2 (COMIRNATY; Solution for injection, unknown lot number and expiration), intramuscular on 18Feb2021 at 0.3 mL, single for COVID-19 immunisation. Medical history included admission/hospitalization on 25Dec2019 due to hematoma in the left basal ganglia with opening to the ventricles of hypertensive origin, dismissed at admission surgical attitude. He remained admitted until 14Feb2020. Upon discharge, the patient was evaluated with neurology which showed predominantly motor mixed dysphasia (emits sounds and some isolated monosyllables, repeats monosyllables, does not nominate, performs 1-2 simple orders and becomes intoxicated with the following and with semi-complexes), right homonymous hemianopia (RHH), mild-moderate right facial paralysis, right hemiplegia with RES spastic component, right anesthesia, thalamus hemorrhage on 25Dec2019, and right extensor CRP, left flexor. The patient previously received Citalopram, Deprax, losartan, and Zolpidem as treatments. The patient received first dose of COMIRNATY vaccine on 18Feb2021. The following day on 19Feb2021, the patient was found with altered/deterioration in level of consciousness without response to painful stimuli, for which he was transferred and admitted to hospital. This was caused by acute intraparenchymal hematoma in the right thalamocapsular region with an intraventricular component. The patient previously was independent for basic activities of daily living (ERM 0, unknown CVRF). Upon arrival, a CT scan was performed, the right jugular central venous line was channeled without immediate complications, and the orotracheal intubation tube was changed due to continuous leakage for tube n8. The neurologist was notified for evaluation and in consensus with the family it was decided not to place a ventricular drain. The patient remained sedated pending neurological evolution due to the poor prognosis, dying on 25Feb2021. Physical examination revealed TA (blood pressure) 165/110, heart rate 90, oxygen saturation 99%, and body temperature 36 degree C. Low effect of sedoanalgesia. Right pupil discoric, not reactive to light. Decerebrate position to painful stimulus. AC: impresses rhythmic AP: good bilateral ventilation without added noise. Abdomen soft, not painful. Lower limbs with pitting edema in right lower limb. On 19Feb2021, non-contrasted brain CT findings (compared with previous CT on 08Jan2021 with unknown result): Hyperdense intraaxial collection measuring 3.5 x 2.7 cm right capsular thalamus compatible with acute intraparenchymal hematoma, which IT is open to the right LV, with blood content occupying the III and IV ventricles. Surrounding the hematoma, a small halo of vasogenic edema is observed. All of this conditions an expansive effect with effacement of the right hemispheric sulci and deviation of the midline structures towards the left by 4 mm. ASH focus in right frontal furrows. Sequelae of hematoma in the region of the left basal ganglia and ipsilateral cerebral peduncle. Rest unchanged from previous CT. Impression: Acute intraparenchymal hematoma in the right capsular thalamus region with an intraventricular component. On the same day, thorax RX showed free costophrenic sinuses, no masses or infiltrates, right jugular central venous route, NGS and orotracheal intubation tube normalized. Diagnosis is acute intraparenchymal hematoma in the right capsular thalamus region with an intraventricular component. Outcome of lower limbs with pitting edema in right lower limb was unknown. Hematoma cerebral stop date on 25Feb2021 reported with fatal outcome. The patient died on 25Feb2021. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Hematoma cerebral/acute intraparenchymal hematoma in the right capsular thalamus region with an intraventricular component
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166